Autism and Metabolic Diseases
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Autism is an etiologic heterogeneous entity caused by many different diseases occurring in the central nervous system at an early stage in life. Several metabolic defects have been associated with autistic symptoms with a rate higher than that found in the general population. Inborn errors of metabolism can probably account for less than 5% of individuals. Selective metabolic testing should be done in the presence of suggestive clinical findings, including lethargy, cyclic vomiting, early seizures, dysmorphic features, and mental retardation. In some patients, early diagnosis of the metabolic disorders and proper therapeutic interventions may significantly improve the long-term cognitive and behavioral outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004) · Pediatrics · doi:10.1542/peds.113.5.e472 · Cited by 1,207
Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095 · cited 1×
“Studies have reported rates of autistic behavior in individuals with Smith-Lemli-Opitz Syndrome ranging from 50% to 86%.(64,65) Cholesterol in the central nervous system(66) may play a role in the synaptogenesis and in the proliferation of glial cells or neurons, or both.”
BackgroundMinicolumnar pathology in autism
Casanova, M. F., Buxhoeveden, D. P., Switala, A. E., & Roy, E. (2002) · Neurology · doi:10.1212/wnl.58.3.428 · Cited by 846
Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome
Tint, G. S., Irons, M., Elias, E. R., Batta, A. K., Frieden, R., Chen, T. S., & Salen, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401133300205 · Cited by 798
Neurosteroids: biochemistry and clinical significance
Mellon, S. H., & Griffin, L. D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00503-3 · Cited by 538
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Specific Genetic Disorders and Autism: Clinical Contribution Towards their Identification
Cohen, D., Pichard, N., Tordjman, S., Baumann, C., Burglen, L., Excoffier, E., Lazar, G., Mazet, P., Pinquier, C., Verloes, A., et al. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-004-1038-2 · Cited by 316 · cited 1×
“became available in the early 1960s and in many developing countries, including Eastern Europe, where screening has not yet been implemented.(23) This disorder can be caused by more than 200 different genetic mutations affecting the functioning of the phenylalanine hydroxylase enzyme.”
BackgroundMicroscopic Neuroanatomic Abnormalities in Autism
Bauman, M. L. (1991) · Pediatrics · doi:10.1542/peds.87.5.791 · Cited by 242
The near universal presence of autism spectrum disorders in children with Smith–Lemli–Opitz syndrome
Sikora, D. M., Pettit‐Kekel, K., Penfield, J., Merkens, L. S., & Steiner, R. D. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31294 · Cited by 196 · cited 1×
“Studies have reported rates of autistic behavior in individuals with Smith-Lemli-Opitz Syndrome ranging from 50% to 86%.(64,65) Cholesterol in the central nervous system(66) may play a role in the synaptogenesis and in the proliferation of glial cells or neurons, or both.”
Background
Cited by
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 907
Autism spectrum disorders-a genetics review
Miles, J. H. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181ff67ba · Cited by 567
Neurometabolic disorders and dysfunction in autism spectrum disorders
Zecavati, N., & Spence, S. J. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0021-x · Cited by 110
Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism
Rivell, A., & Mattson, M. P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.08.006 · Cited by 50
Variability of Creatine Metabolism Genes in Children with Autism Spectrum Disorder
Cameron, J. M., Levandovskiy, V., Roberts, W., Anagnostou, E., Scherer, S., Loh, A., & Schulze, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081665 · Cited by 15
“Less than 5% of ASD cases can be attributed to routinely-screened-for inborn errors of metabolism [2,3].”
Background
Metadata
- Authors
- Manzi, B., Loizzo, A. L., Giana, G., & Curatolo, P.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2008-01-11
- Volume
- 23
- Issue
- 3
- Pages
- 307-314
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W1987345438
- Cited by
- 118
- References
- 14
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autism and Metabolic Diseases. https://app.cochat.ai/papers/10.1177/0883073807308698
- The paper
- Manzi, B., Loizzo, A. L., Giana, G., & Curatolo, P. (2008). Autism and Metabolic Diseases. Journal of Child Neurology. https://doi.org/10.1177/0883073807308698
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.